Print

Genmab A/S (GEN.CO) Announces Appeal of US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit  
12/6/2011 10:12:16 AM

COPENHAGEN, Denmark, Dec. 6, 2011 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN) announced today that Genentech and Biogen Idec have appealed the judgment in favor of GlaxoSmithKline (GSK) in a patent infringement case involving Arzerra brought against GSK by Genentech and Biogen Idec.
//-->